Dysregulation of m6A “writer” protein, methyltransferase-like 3 (METTL3) and methyltransferase-like 14 (METTL14), has been reported in liver cancer [11, 12], lung cancer [9] and glioblastoma [13]. This evidence concerns the gene METTL14 and lung carcinoma.